A total of 1,197 patients were randomized in a 2:1 ratio to receive semaglutide 2.4 mg subcutaneously once weekly or placebo for 240 weeks
Precautions for Sensitive Groups: Patients with a history of mental health conditions, diabetic retinopathy, or cardiovascular conditions should discuss these with their provider before starting
Key Takeaways Proven Efficacy: Injectable tirzepatide demonstrates significant weight loss in clinical trials
11+ YEAR OLD BRAND | 20 LAKH+ CUSTOMERS SERVED: MyFitFuel was first in India in year 2013 to bring knowledge on 100% Transparency including information on cheap fillers, thickeners and now in year 2017 we are first in India to bring better education on knowledge of Dry basis Protein vs As is basis protein
Staying informed, asking questions, and working with a healthcare provider will help ensure that both medications work safely and as expected
Is semaglutide available without a prescription